Practice Questions

Anticoagulant NCLEX Practice Questions: Heparin, Warfarin and DOACs

Anticoagulant items test whether you can pair each drug with the lab value that tracks it, the agent that reverses it, and the complication that matters most. Work through these 10 practice questions on heparin and the aPTT, enoxaparin dosing and safety, warfarin with the INR and vitamin K, and DOACs such as apixaban and rivaroxaban; answer each one, then reveal the correct answer and see why every option is right or wrong. No sign-up needed to practice here.

High-Yield Anticoagulant Review: Heparin, Warfarin & DOACs

Unfractionated heparin can be given IV or subcutaneously, and an IV dose acts at once. A continuous infusion is monitored with the aPTT (the heparin label defines an adequate dose as about 1.5 to 2 times normal, many nursing references teach 1.5 to 2.5 times control, and the facility nomogram sets the target in seconds) or an anti-Xa level (commonly about 0.3-0.7 units/mL). These samples are drawn from the arm opposite the infusion, because blood taken above the IV site picks up heparin and reads falsely high. Low-dose subcutaneous heparin for prevention usually needs no aPTT. The platelet count is measured before therapy and at intervals afterward to catch heparin-induced thrombocytopenia (HIT), and because the heparin label lists a history of HIT as a contraindication, heparin-containing products such as catheter lock flushes are questioned for these clients. Bleeding can be hidden: an unexplained drop in hemoglobin or blood pressure, or new back or flank pain, can signal retroperitoneal bleeding. The reversal agent is protamine sulfate, given very slowly (no more than 50 mg over 10 minutes); clients who have used NPH insulin or received protamine before are at higher risk of a severe reaction, and fish allergy or a previous vasectomy may also raise the risk. Because heparin is on the high-alert medication list, a second nurse independently verifies infusion calculations and pump settings when facility policy requires it.

Enoxaparin belongs to the low-molecular-weight heparin (LMWH) class. It is injected deep subcutaneously into the abdominal wall with the client lying down, switching sides from one dose to the next; the nurse does not push the air bubble out of a prefilled syringe before injecting and does not massage the site afterward. Treatment doses are weight-based (for example, 1 mg/kg given every 12 hours to treat a DVT), so the nurse converts pounds to kilograms and, with a graduated syringe, ejects the excess until only the prescribed dose remains. Routine aPTT checks are not used for enoxaparin; instead, the nurse tracks the complete blood count, the platelet count, and any signs of bleeding. Its boxed warning is spinal or epidural hematoma after neuraxial anesthesia, an epidural catheter, or a spinal puncture: new back pain, leg numbness or weakness, or bowel or bladder changes are reported immediately because paralysis can result.

Warfarin, a vitamin K antagonist taken by mouth, stops the liver from producing working forms of factor II (prothrombin), VII, IX, and X. Its anticoagulant effect peaks only after 72-96 hours. Warfarin is monitored with the PT/INR: most clients, including those with atrial fibrillation, DVT, or pulmonary embolism, aim for 2.0-3.0, while a mechanical mitral valve calls for a higher range of 2.5-3.5. If the INR comes back above goal, the nurse checks for bleeding and reports the value; the provider then decides whether the next dose is held or reduced. Phytonadione (vitamin K) lets the liver make working clotting factors again, which takes hours, so major bleeding is treated with IV vitamin K plus 4F-PCC (4-factor prothrombin complex concentrate), which supplies those factors right away. Teaching centers on a steady vitamin K intake (greens are not off-limits), reporting illnesses such as severe diarrhea, and checking with the provider before any drug or herbal product is started or stopped, since a diet change, an illness, or a medication change can each call for an earlier INR check. Warfarin is contraindicated in pregnancy except for some clients with mechanical heart valves, so a possible pregnancy needs prompt follow-up.

The DOACs work on two targets: apixaban, rivaroxaban, and edoxaban block factor Xa, while dabigatran blocks thrombin directly. They are given in fixed doses without routine INR or aPTT checks, but kidney function is reviewed periodically. Rivaroxaban 15 mg and 20 mg tablets are taken with food (with the evening meal for atrial fibrillation), and dabigatran capsules are swallowed whole. When a client switches from warfarin, warfarin is stopped and the DOAC is started once the INR falls below the threshold in its label: below 2.0 for apixaban and dabigatran, below 3.0 for rivaroxaban. Stopping any anticoagulant early raises the risk of stroke and clots. Idarucizumab reverses dabigatran. Andexanet alfa, which was approved to reverse apixaban and rivaroxaban, left the U.S. market in 2025, so bleeding on a factor Xa inhibitor is now usually managed with 4F-PCC. Black stools, new confusion, tachycardia, or hypotension in a client on any anticoagulant can point to active bleeding; the nurse holds the drug, checks circulation, calls the provider, and readies the matching reversal agent. Any head injury, even a minor bump, is reported to the provider, because bleeding inside the skull may not cause symptoms such as a severe headache, vomiting, or drowsiness until hours later. For the full side-by-side comparison, see our heparin vs warfarin guide, and keep every drug-antidote pairing straight with the antidotes and reversal agents table.

Heparin NCLEX Practice Questions

Question 1 · Heparin and the Anti-Xa Level

A client with a right-leg deep vein thrombosis is receiving heparin through an IV site on the left forearm. The facility protocol adjusts the rate to keep the anti-factor Xa (anti-Xa) level between 0.3 and 0.7 units/mL. The two previous levels, drawn at the current rate, were 0.48 and 0.55 units/mL. This morning's level is 1.6 units/mL. The rate has not changed, there is no bleeding or new bruising, and vital signs match the client's baseline. The collection record shows that the sample was drawn from the left antecubital vein, above the infusion site. Which step should the nurse take first?

  • A Hold the infusion for 1 hour, then restart it at the lower rate the protocol lists for a high level
  • B Prepare to give protamine sulfate to neutralize the excess heparin
  • C Leave the rate as it is and wait for the anti-Xa level due with tomorrow morning's labs
  • D Request a repeat anti-Xa level drawn from the right arm before making any rate change
Show answer & rationale
Correct answer: D

An anti-Xa level measures heparin activity in the blood, and many facilities use it instead of the aPTT to adjust heparin infusions. Many protocols target about 0.3-0.7 units/mL for unfractionated heparin, though facility ranges vary. The result is only useful if the sample is valid. Blood drawn from the same arm above an infusion site mixes with the heparin solution traveling up the vein, so the level reads falsely high. Coagulation samples are drawn from a site away from the IV line, usually the opposite arm.

(D) is correct because a jump to 1.6 units/mL with no rate change, no bleeding, and two steady in-range levels points to a contaminated sample, and the collection site explains it. The nurse requests a repeat level from the right arm, opposite the infusion, reports the questionable result per facility policy, keeps assessing for bleeding, and applies the protocol to the valid result.

(A) is incorrect because a hold followed by a lower rate is what the protocol directs when a high level is real. This result most likely reflects heparin from the IV solution that entered the sample, not heparin in the client's circulation, and cutting the dose could leave the clot under-treated. (B) is incorrect because protamine is reserved for serious bleeding or a large overdose and needs a provider's prescription; this client is not bleeding, and the high level is probably not real. (C) is incorrect because a result this far above the range cannot wait a full day. If it were real, the client would stay over-anticoagulated for about 24 more hours, so it has to be confirmed now with a properly drawn sample.

Clinical pearl: When a heparin lab result does not fit the clinical picture, check how the sample was collected before changing the infusion. Draw anti-Xa and aPTT samples from the arm opposite the heparin infusion, and repeat a suspect result first.

Question 2 · History of HIT

A client with a documented history of heparin-induced thrombocytopenia (HIT) 2 years ago is admitted with pneumonia. A tunneled central venous catheter is in place, and the platelet count and kidney function are within normal limits. Which admission order should the nurse question before acting on it?

  • A Heparin lock flush solution into each catheter lumen after every use
  • B Sodium chloride 0.9% flush, 10 mL into each lumen before and after each medication
  • C Fondaparinux 2.5 mg subcutaneously once daily to prevent venous thromboembolism
  • D Sequential compression devices on both legs while in bed
Show answer & rationale
Correct answer: A

A history of HIT is a contraindication to heparin, and that includes the small amounts used to lock IV catheters. The nurse questions every heparin-containing product for this client.

(A) is correct because the heparin label lists a history of heparin-induced thrombocytopenia as a contraindication, and a lock flush is still a heparin product. The nurse holds the flush and requests a non-heparin alternative from the provider, usually a saline lock per facility policy.

(B) is incorrect because a saline flush contains no heparin and is the expected way to keep this client's lumens patent. (C) is incorrect because fondaparinux is not a heparin; the American Society of Hematology lists it among the non-heparin anticoagulants recommended for VTE prevention in clients with a past history of HIT, and the client's normal kidney function matters because fondaparinux depends on the kidneys for clearance. (D) is incorrect because the compression devices provide mechanical VTE prevention and involve no heparin.

Clinical pearl: A past episode of HIT means every heparin source is questioned, including catheter lock flushes and subcutaneous heparin; expect saline locks and non-heparin anticoagulants instead.

Question 3 · Protamine Sulfate Safety

During a heparin infusion started after surgery, a client develops brisk bleeding from the incision. The provider stops the infusion and prescribes protamine sulfate IV. Before giving the protamine, which part of the client's history needs to be brought to the provider's attention?

  • A Takes levothyroxine every morning for hypothyroidism
  • B Had a rash after taking penicillin as a child
  • C Has used NPH insulin twice daily for 12 years
  • D Takes omeprazole daily for acid reflux
Show answer & rationale
Correct answer: C

Protamine sulfate neutralizes heparin, but its boxed warning covers severe hypotension, cardiovascular collapse, noncardiogenic pulmonary edema, and pulmonary hypertension. Risk factors on the label include rapid administration, high doses, previous protamine exposure, current or previous use of protamine-containing insulin (NPH or protamine zinc insulin), fish allergy, and previous vasectomy.

(C) is correct because NPH (isophane) insulin contains protamine, so years of use can sensitize the client and raise the risk of a severe or anaphylactic reaction. The provider weighs that risk, and the nurse gives the dose very slowly (no more than 50 mg over 10 minutes), monitors blood pressure and heart rate closely, and has resuscitation equipment and anaphylaxis treatment ready.

(A) is incorrect because levothyroxine has no known link to protamine reactions. (B) is incorrect because a penicillin allergy is not among the risk factors listed for protamine reactions; it matters when antibiotics are chosen. (D) is incorrect because omeprazole has no known interaction with protamine and plays no part in protamine reactions.

Clinical pearl: Before giving protamine, check for protamine-containing insulin use, fish allergy, prior protamine exposure, and vasectomy; give it slowly and be ready to treat hypotension and anaphylaxis.

Enoxaparin (LMWH) NCLEX Practice Questions

Question 4 · Enoxaparin Dosage Calculation

A client who weighs 132 lb is prescribed enoxaparin 1 mg/kg subcutaneously every 12 hours to treat a deep vein thrombosis. The pharmacy supplies an 80 mg/0.8 mL graduated prefilled syringe. What volume should the nurse inject?

  • A 0.3 mL
  • B 0.6 mL
  • C 0.8 mL
  • D 1.32 mL
Show answer & rationale
Correct answer: B

First change pounds to kilograms, then find the dose in mg, then the volume in mL. 132 lb ÷ 2.2 lb/kg = 60 kg. 60 kg × 1 mg/kg = 60 mg. The syringe holds 80 mg in 0.8 mL, which is 100 mg/mL, so 60 mg ÷ 100 mg/mL = 0.6 mL.

(B) is correct because 0.6 mL of enoxaparin 100 mg/mL delivers exactly the prescribed 60 mg. Because the full syringe holds more than the dose, the nurse ejects the excess until the 60 mg mark remains, as the label directs for graduated syringes, and follows facility policy for an independent double-check of this high-alert medication.

(A) is incorrect because injecting 0.3 mL delivers 30 mg, half the prescribed dose; the every-12-hour dose is already the amount for one injection and is not divided again. (C) is incorrect because 0.8 mL is the full syringe, 80 mg, which is 20 mg more than prescribed. (D) is incorrect because 1.32 mL results when the weight in pounds is used as if it were kilograms (132 mg), more than twice the correct dose.

Clinical pearl: For weight-based enoxaparin, convert pounds to kilograms first, calculate the dose in mg, then the volume in mL; with a graduated syringe, eject the excess so only the prescribed dose remains.

Question 5 · Enoxaparin and Epidural Hematoma

Two days have passed since a client's total knee arthroplasty. The epidural catheter used for pain control was removed yesterday afternoon, and enoxaparin 30 mg every 12 hours by subcutaneous injection was started 4 hours after removal. This morning the client used a walker to get to the bathroom. At 1400, the client reports new numbness and weakness in both legs and a backache, and the nurse confirms decreased sensation and strength in both lower extremities. Which nursing action comes first?

  • A Report the new neurologic deficits to the provider now and hold the next enoxaparin dose
  • B Document the findings as a lingering effect of the epidural anesthetic and recheck in 2 hours
  • C Help the client walk to the chair to evaluate leg strength
  • D Give the prescribed as-needed oxycodone for the backache and reassess in 1 hour
Show answer & rationale
Correct answer: A

Enoxaparin carries a boxed warning for epidural or spinal hematoma in clients who have had neuraxial anesthesia, an indwelling epidural catheter, or a spinal puncture. A hematoma can compress the spinal cord and cause long-term or permanent paralysis, so the label calls for frequent neurologic checks and urgent diagnosis and treatment when signs appear.

(A) is correct because backache plus new numbness and weakness in both legs, appearing after the client had already been walking, is the classic picture of a spinal or epidural hematoma. This is an emergency: the provider needs to know now so imaging and possible surgical decompression are not delayed, and further anticoagulant doses are held until the provider decides.

(B) is incorrect because the catheter was removed about a day ago and the client had regained enough strength to walk; new deficits after function has returned are not a lingering anesthetic effect, and waiting 2 hours risks permanent injury. (C) is incorrect because walking a client with new leg weakness invites a fall and delays reporting. (D) is incorrect because an opioid for the backache can mask a worsening problem and delays urgent evaluation.

Clinical pearl: After an epidural or spinal procedure, a client on enoxaparin with new back pain, leg numbness or weakness, or bowel or bladder changes needs immediate provider notification for a suspected spinal or epidural hematoma.

Want more practice questions? Create a free NCLEX Key account →

Warfarin NCLEX Practice Questions: INR & Vitamin K

Question 6 · INR Targets by Indication

The nurse in an anticoagulation clinic reviews today's INR results for four clients who take warfarin. Which client's result needs to go to the provider for a possible dose change?

  • A A client with atrial fibrillation: INR 2.7
  • B A client with a DVT diagnosed last month: INR 2.2
  • C A client who had a pulmonary embolism 2 months ago: INR 2.9
  • D A client with a mechanical mitral valve: INR 2.1
Show answer & rationale
Correct answer: D

The INR goal depends on the reason for warfarin. Per the warfarin label, the target is 2.5 (acceptable range 2.0-3.0) when the indication is atrial fibrillation or treatment of a DVT or pulmonary embolism, but 3.0 (range 2.5-3.5) when a mechanical valve sits in the mitral position, because these valves carry a high risk of clotting.

(D) is correct because an INR of 2.1 is below the 2.5-3.5 range for a mechanical mitral valve. Under-anticoagulation puts this client at risk of valve thrombosis and embolic stroke, so the result is reported for a dose adjustment and closer follow-up.

(A) is incorrect because 2.7 is within the 2.0-3.0 range for atrial fibrillation. (B) is incorrect because 2.2 is within the 2.0-3.0 range for DVT treatment. (C) is incorrect because 2.9 is within the 2.0-3.0 range for pulmonary embolism treatment.

Clinical pearl: Interpret every INR against the client's indication: most clients, including those with atrial fibrillation or venous thromboembolism, aim for 2.0-3.0, and a mechanical mitral valve needs 2.5-3.5.

Question 7 · Warfarin and Pregnancy

A 31-year-old client on warfarin for a deep vein thrombosis diagnosed 2 months ago calls the clinic. Which of the client's statements should the nurse address first?

  • A "I take my warfarin at the same time every evening."
  • B "I got a small bruise on my shin when I bumped the coffee table."
  • C "My home pregnancy test was positive this morning."
  • D "I eat a spinach salad for lunch about three times a week."
Show answer & rationale
Correct answer: C

Warfarin crosses the placenta. The label states that it is contraindicated in pregnancy except in some clients with mechanical heart valves, because exposure can cause warfarin embryopathy (such as nasal hypoplasia and stippled bone growth centers), fetal bleeding, and pregnancy loss.

(C) is correct because a possible pregnancy in a client taking warfarin needs same-day provider follow-up. The provider will confirm the pregnancy and switch the client to an anticoagulant suited to pregnancy, usually enoxaparin or another low-molecular-weight heparin. The client should not stop anticoagulation without guidance, because the DVT still needs treatment.

(A) is incorrect because a consistent daily dosing time is correct practice. (B) is incorrect because minor bruising after a bump is expected with anticoagulation; the client should report bruising that is large, unexplained, or spreading. (D) is incorrect because a steady, consistent intake of vitamin K foods is exactly what the client is taught to maintain.

Clinical pearl: Warfarin is contraindicated in pregnancy for most clients; report a possible pregnancy promptly so the provider can switch to a pregnancy-appropriate anticoagulant without a gap in treatment.

Question 8 · Changes That Affect the INR

A client whose INR has been stable on the same warfarin dose for 6 months describes several recent changes at a clinic visit. Which changes should prompt the nurse to arrange an earlier INR check? Select all that apply.

  • A Began a 30-minute walking program each morning with a neighbor last month
  • B Started taking amiodarone for an irregular heartbeat last week
  • C Switched from a blade to an electric razor for shaving, as the nurse taught
  • D Has had diarrhea and has eaten very little for the past 4 days
  • E Started drinking a vitamin K-fortified nutrition shake twice a day
Show answer & rationale
Correct answer: B, D, E

The warfarin label advises checking the INR more often whenever other drugs are started or stopped, and it lists diet and illness among the factors that change the INR. A change can push the INR up (bleeding risk) or down (clotting risk), and both matter.

(A) is incorrect because regular walking does not change warfarin's effect; it should be encouraged.

(B) is correct because amiodarone inhibits the liver enzymes that clear warfarin and is listed on the label as an interacting drug that raises its effect. The INR is checked sooner, and the warfarin dose is often lowered.

(C) is incorrect because an electric razor is a bleeding precaution that reduces nicks; it does not change the INR.

(D) is correct because the label lists diarrhea and a poor nutritional state as factors that can increase the INR response, and clients are taught to report severe diarrhea or illness.

(E) is correct because a sudden increase in vitamin K intake can lower the INR response and raise the risk of clotting; the label advises avoiding drastic changes in diet, and the dose may need adjustment.

Clinical pearl: Arrange an earlier INR check when a client on warfarin starts or stops a medication, has an illness that causes diarrhea or poor intake, or changes vitamin K intake. A higher INR and a lower INR are both risks.

DOAC NCLEX Practice Questions: Apixaban & Rivaroxaban

Question 9 · Switching Warfarin to Apixaban

The provider is changing a client's anticoagulant for atrial fibrillation from warfarin to apixaban. The last warfarin dose was 2 days ago, and today's INR is 2.6. The client asks, "Should I take my first apixaban tablet now?" How should the nurse respond?

  • A "Yes, take it now so that you are not without protection against a stroke."
  • B "Apixaban starts once your INR is below 2.0, so we will recheck it first."
  • C "You will take both drugs together for 5 days, until your INR is above 2.0."
  • D "First you'll be given a dose of vitamin K to bring your INR down."
Show answer & rationale
Correct answer: B

Warfarin's effect fades over several days after the last dose. To avoid stacking two anticoagulants, the apixaban label directs that warfarin be stopped and apixaban started when the INR is below 2.0. Each DOAC label sets its own threshold: below 2.0 for apixaban and dabigatran, and below 3.0 for rivaroxaban.

(B) is correct because an INR of 2.6 shows that warfarin is still anticoagulating the client. Starting apixaban now would combine two anticoagulants and increase bleeding risk, so the INR is rechecked and apixaban begins once the INR is below 2.0, per the prescriber's plan.

(A) is incorrect because at an INR of 2.6 the client is still protected by warfarin; adding apixaban now raises bleeding risk without added benefit. (C) is incorrect because overlapping two drugs until the INR is therapeutic describes starting warfarin with a heparin, not switching to a DOAC. (D) is incorrect because vitamin K is a reversal agent for warfarin-related bleeding or a markedly high INR; it is not part of a routine, planned switch.

Clinical pearl: When switching from warfarin to a DOAC, stop warfarin and start the DOAC when the INR falls below the threshold in its label (below 2.0 for apixaban), without overlapping the two drugs.

Question 10 · Rivaroxaban Client Teaching

The nurse reinforces discharge teaching for a client newly prescribed rivaroxaban 20 mg once daily for atrial fibrillation. The client's kidney function is normal. Which client statements show that the teaching was understood? Select all that apply.

  • A "I'll take my tablet with my evening meal."
  • B "I'll get my INR checked every week so my dose can be adjusted."
  • C "Before any dental work, I'll let my dentist know I'm on this medicine."
  • D "Once my heartbeat feels normal again, I can stop taking it."
  • E "If it's hard to swallow, I can crush it and stir it into applesauce."
  • F "I'll call right away if I notice black stools or pink urine."
Show answer & rationale
Correct answer: A, C, E, F

Rivaroxaban is a factor Xa inhibitor given at a fixed dose. For atrial fibrillation, the 20 mg dose (for clients with adequate kidney function) is taken once daily with the evening meal, because food improves absorption of the 15 mg and 20 mg tablets.

(A) is correct because clients with atrial fibrillation are instructed to take rivaroxaban once daily with the evening meal.

(B) is incorrect because rivaroxaban does not use INR-guided dosing; the label states that monitoring its effect with the PT, INR, or aPTT is not recommended.

(C) is correct because clients should tell every provider, including the dentist, that they take rivaroxaban before any invasive or dental procedure so it can be planned for safely.

(D) is incorrect because stopping an anticoagulant early increases the risk of stroke and other clots, which is a boxed warning for rivaroxaban; the medicine is continued even if the client feels fine, unless the provider stops it.

(E) is correct because the label allows rivaroxaban tablets to be crushed and mixed with applesauce right before use for clients who cannot swallow them whole. A crushed 15 mg or 20 mg dose is followed right away by food, which fits this client's evening-meal dosing. Dabigatran is different: its capsules must be swallowed whole.

(F) is correct because black or tarry stools and pink, red, or brown urine are signs of bleeding that should be reported promptly.

Clinical pearl: Teach clients taking rivaroxaban for atrial fibrillation to take each dose with the evening meal (a crushed tablet in applesauce is acceptable if swallowing is hard), never stop it without the provider, tell all providers and dentists, and report signs of bleeding. No INR monitoring is needed.

Want more practice questions? Create a free NCLEX Key account — NCLEX-style questions with a full rationale on every answer. No credit card.

Start practicing free →

Anticoagulant NCLEX FAQ

Which lab tests monitor heparin, warfarin, enoxaparin, and DOACs?

For unfractionated heparin, the aPTT is the usual test (the label treats 1.5 to 2 times normal as an adequate dose, many nursing references teach 1.5 to 2.5 times control, and the facility nomogram gives the target in seconds); some hospitals titrate to an anti-Xa level instead. Warfarin is tracked with the PT/INR; the target range for most clients is 2.0-3.0, while a mechanical mitral valve raises it to 2.5-3.5. Enoxaparin is not tracked with the aPTT; the CBC and platelet count are followed instead. DOACs do not require routine INR or aPTT testing, although kidney function is rechecked from time to time. Memory aid: aPTT and protamine belong to heparin; PT/INR and vitamin K belong to warfarin.

What are the reversal agents for heparin, warfarin, and DOACs?

Protamine sulfate fully reverses unfractionated heparin but only partly reverses enoxaparin. The antidote for warfarin is vitamin K (phytonadione), which works over hours; for major bleeding, IV vitamin K is given together with 4F-PCC, a 4-factor prothrombin complex concentrate. Idarucizumab reverses dabigatran. Because andexanet alfa left the U.S. market in 2025, 4F-PCC has become the usual choice for bleeding on apixaban, rivaroxaban, or edoxaban. Neither protamine nor vitamin K is expected to undo a DOAC's effect. See the full antidotes and reversal agents table.

Do clients taking warfarin need to avoid green leafy vegetables?

No. The teaching point is consistency, not avoidance. Vitamin K-rich foods such as spinach and kale oppose warfarin, so a sudden large increase can lower the INR and a sudden decrease can raise it. Clients keep their usual amount of these foods steady and check with the provider before starting or stopping any drug or herbal product, because many interact with warfarin: the INR can climb with amiodarone, fluconazole, or metronidazole, and fall with St. John's wort.

Which step comes first when a client on an anticoagulant shows signs of bleeding?

With signs of active bleeding (black stools, new confusion, tachycardia, or hypotension), stop the anticoagulant first; for a heparin infusion, that means shutting it off. Then check circulation, inform the provider, and get the specific reversal agent ready; giving it requires a provider's prescription. For an INR above goal with no visible bleeding, still assess for bleeding and report the result before the next warfarin dose, which the provider may hold or lower. Report any head injury to the provider, even a minor bump with no symptoms yet, and keep checking the level of consciousness over the next several hours, because bleeding inside the skull can build slowly.

Sources

Sources checked October 2026.